These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32914681)

  • 1. Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.
    Nawata M; Nagayasu A; Fujita Y; Nawata A; Saito K; Tanaka Y
    Lupus; 2020 Dec; 29(14):1955-1960. PubMed ID: 32914681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren's syndrome.
    Yucel H; Vollmer O; Canuet M; Enache I; Kessler R; Korganow AS; Riou M
    Lupus; 2021 Mar; 30(3):510-513. PubMed ID: 33655792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal Management and Long-Term Follow-up of a Primipara With Severe Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus.
    Song W; Chu S; Yang K; Sun X; Xia H; Mei C; Zhao Y; Wu J
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2511-2517. PubMed ID: 34247927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus-associated pulmonary arterial hypertension.
    Sanges S; Savale L; Lamblin N; Rémy-Jardin M; Humbert M; Sobanski V
    ESC Heart Fail; 2019 Dec; 6(6):1322-1325. PubMed ID: 31536678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature.
    Prete M; Fatone MC; Vacca A; Racanelli V; Perosa F
    Clin Exp Rheumatol; 2014; 32(2):267-74. PubMed ID: 24351505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.
    Saiki C; Kashiwado Y; Yokoyama T; Ayano M; Imabayashi K; Kawano S; Higashioka K; Kimoto Y; Fukata M; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):183-188. PubMed ID: 35134204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment by mycophenolate mofetil of subacute progressive interstitial lung disease associated with systemic lupus erythematosus.
    Hanata N; Shoda H; Fujio K
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):43-46. PubMed ID: 33269649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
    Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
    Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Unexpected Cause of Lung Disease Identified After Lung Transplantation.
    Self A; Afshar K; Kafi A; Yung G; Golts E; Lin CM
    Chest; 2023 Oct; 164(4):e111-e115. PubMed ID: 37805248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of systemic lupus erythematosus with pulmonary hypertension].
    Nakano K; Tanaka Y; Aso M; Saito K; Fujii K; Takazawa A; Ota T
    Ryumachi; 2000 Jun; 40(3):612-9. PubMed ID: 10920686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of interstitial pneumonia associated with systemic lupus erythematosus.
    Toyoda Y; Koyama K; Kawano H; Nishimura H; Kagawa K; Morizumi S; Naito N; Sato S; Yamashita Y; Takahashi N; Goto H; Azuma M; Nishioka Y
    Respir Investig; 2019 Sep; 57(5):435-443. PubMed ID: 31235450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus-pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medical Data Vision Database in Japan.
    Atsumi T; Tan JY; Chiang AP; Yu DY; Makanji Y; Wu DB; Casorso J; Kouhkamari M; Lim S
    Mod Rheumatol; 2024 Jul; 34(4):741-749. PubMed ID: 37747781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients.
    Donnarumma JFS; Ferreira EVM; Ota-Arakaki J; Kayser C
    Adv Rheumatol; 2019 Jan; 59(1):1. PubMed ID: 30657102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.
    Huang C; Li M; Liu Y; Wang Q; Guo X; Zhao J; Lai J; Tian Z; Zhao Y; Zeng X
    Medicine (Baltimore); 2016 Mar; 95(10):e2761. PubMed ID: 26962774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.
    Yang GL; Guo J; Pudasaini B; Yuan P; Gong SG; Wang L; Zhao QH; Yang WL; Jiang R; Zhou C; Liu JM
    Clin Respir J; 2019 Sep; 13(9):545-554. PubMed ID: 31295761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines.
    Li Y; Qian J; Dong X; Zhao J; Wang Q; Wang Y; Zeng X; Tian Z; Li M
    Arthritis Res Ther; 2024 May; 26(1):109. PubMed ID: 38802957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN; Karim Y; Cuadrado MJ
    Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of mycophenolate mofetil for systemic lupus erythematosus].
    Suzuki D; Ogawa N; Sawada J; Kimoto O; Shimoyama K; Hayashi H
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug; 32(4):263-8. PubMed ID: 19721347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.